Keytruda Qlex 790 mg / 9600 UNT in 4.8 mL Injection
RxNorm 2723772
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2723772 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Keytruda Qlex 790 mg / 9600 UNT in 4.8 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
4.8 mL berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 mg/ML Injection [Keytruda Qlex]
(Atom ID: 12999697)
SYPrescribable
Synonym (SY):
Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph 790 mg / 9600 UNT) per 4.8 mL Injection
(Atom ID: 12999699)
PSNPrescribable